SOMANETICS CORP 4
4 · SOMANETICS CORP · Filed Jul 28, 2010
Insider Transaction Report
Form 4
SOMANETICS CORPSMTS
SORENSEN RICHARD R
Director
Transactions
- Disposition to Issuer
Director stock option (right to buy)
2010-07-27$8.18/sh−10,000$81,800→ 0 totalExercise: $16.82Exp: 2018-04-10→ Common Shares (10,000 underlying) - Disposition to Issuer
Director stock opiton (right to buy)
2010-07-27$9.67/sh−10,000$96,700→ 0 totalExercise: $15.33Exp: 2016-06-13→ Common Shares (10,000 underlying) - Disposition to Issuer
Director stock option (right to buy)
2010-07-27$10.23/sh−10,000$102,300→ 0 totalExercise: $14.77Exp: 2019-04-23→ Common Shares (10,000 underlying) - Disposition to Issuer
Director stock option (right to buy)
2010-07-27$5.67/sh−10,000$56,700→ 0 totalExercise: $19.33Exp: 2017-06-13→ Common Shares (10,000 underlying)
Footnotes (4)
- [F1]The option vested in five equal annual installments beginning on 6/13/07 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
- [F2]The option vested in five equal annual installments beginning on 6/13/08 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
- [F3]The option vested in five equal annual installments beginning on 4/10/09 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
- [F4]The option vested in five equal annual installments beginning on 4/23/10 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010